Document is current
Any future updates will be listed below
-
Authors
Heitmann, Berit L.
Køster-Rasmussen, Rasmus
Meyer, Lene B.
Larsen, Sofus C.
Thorsteinsdottir, Fanney
Sandholdt, Catharina T.
Bojsen-Møller, Kirstine N.
Overbeck, Gritt
Waldorff, Frans B.
Kousgaard, Marius B.
Specht, Ina O.
Dirksen, Carsten
-
Funding
Funding for this research was provided by:
The Novo Nordic Foundation (NNF22SA0080921)
- License Information
-
More Information
Article History
Accepted: 26 August 2024
First Online: 17 September 2024
Declarations
:
: Berit L Heitmann, Frans B Waldorf and Carsten Dirksen: Are principal or Co-principal investigators of the LightCOM project that was financed by a grant to the University of Copenhagen and The greater Copenhagen Hospital Corporation from the Novo Nordic Foundation (NNF22SA0080921). Rasmus Køster-Rasmussen, Lene B Meyer, Marius B Kousgaard, Gritt Overbeck and Catharina Thiel Sandholdt: Are part of the LightCOM project that was financed by a grant to the University of Copenhagen from the Novo Nordic Foundation. Rasmus Køster-Rasmussen is further employed as a regular associate professor (50%) at the University of Copenhagen to develop and test a weight-neutral health intervention. Receives a standard consultant fee for teaching courses about weight-neutral health for nurses and staff in general practice. The Danish Medical Association (the National Association of General Practitioners) organizes the courses. Kirstine N Boysen-Møller received funding from the Novo Nordisk Foundation, The Independent Research Fund Denmark and The Amager Hvidovre Hospital research fund. Research grants are administered by The greater Copenhagen Hospital Corporation. Carsten Dirksen: Further received funding from University of Copenhagen and from the Novo Nordic Foundation’s pre-graduate scholarship. Research grants are administered by The greater Copenhagen Hospital Corporation. Consults for Novo Nordic Denmark A/S (2022-2026). Received payment or honoraria for lectures or presentations from Novo Nordisk A/S, Novo Nordisk Denmark A/S, Novo Nordisk France (2024-02) and AstraZeneca A/S. Has received support for attending meetings and/or travel from Novo Nordisk Denmark A/S. Participation in Advisory Board for Novo Nordisk Denmark A/S. Chairperson for the Capital Region’s Endocrine Specialist Forum, sponsored by Novo Nordisk Denmark A/S. Received DexCom CGM sensors and receivers for the LightCOM trial (NCT06309238). All other authors have no conflict of interest to declare.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
